Global Gene Synthesis research

Gene Synthesis Comprehensive Study by Type (Gene Library Synthesis, Custom Gene Synthesis), Application (Industrial, Academic, Therapeutics, Diagnostics), Method (Solid Phase Synthesis, Chip Based DNA Synthesis, PCR Based Enzymes Synthesis), End User (Contract Research Organizations, Biopharmaceutical Companies) Players and Region - Global Market Outlook to 2030

Gene Synthesis Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 16.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Gene Synthesis
Gene synthesis refers to the synthetic biology method used for artificial genes engineering within a laboratory setting. Growing field of biological and life science research propelling the growth of gene synthesis. Market players are focus on the technological advancement for the advanced techniques and tools for gene synthesis. Further growing healthcare infrastructure in the developing economies and increasing demand for the custom gene synthesis expected to drive the demand for gene synthesis market over the forecasted period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR16.1%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Gene Synthesis market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific, Inc. (United States), Genewiz (United States), Eurofins Scientific (Luxembourg), ATD Bio Ltd. (United Kingdom), OriGene Technologies, Inc. (United States), Bioneer Corporation (South Korea), Integrated DNA Technologies, Inc. (United States), GenScript Biotech Corporation (United States) and Eurogentec (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are ATDBio Ltd (United Kingdom), Vigene Biosciences (United States) and Synbio Technologies (United States).

Segmentation Overview
AMA Research has segmented the market of Global Gene Synthesis market by Type (Gene Library Synthesis and Custom Gene Synthesis), Application (Industrial, Academic, Therapeutics and Diagnostics) and Region.



On the basis of geography, the market of Gene Synthesis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Method, the sub-segment i.e. Solid Phase Synthesis will boost the Gene Synthesis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Contract Research Organizations will boost the Gene Synthesis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Applications in the Recombinant DNA Technology and Technological Advancement in the Gene Synthesis Techniques and Tools

Market Growth Drivers:
Growing Emphasis on Clinical Research and Increasing Focus on the Life Science Research

Challenges:
Lack of Advanced Healthcare Facilities in the Emerging Economies

Restraints:
Stringent Government Regulations Regarding Gene Synthesis and High Cost Associated With Gene Synthesis Process

Opportunities:
Increasing Demand for Custom Gene Synthesis Method and Growing Healthcare Infrastructure in the Developing Economies

Market Leaders and their expansionary development strategies
In October 26, 2023, Twist Bioscience partners with WuXi AppTec to offer integrated gene synthesis and protein expression services. This collaboration aims to streamline the process for researchers and drug developers.
In May 10, 2023, Synthego unveils a new platform for high-throughput gene synthesis, enabling the rapid creation of large libraries of DNA constructs. This technology has applications in drug discovery, synthetic biology, and other fields.
“The United States Department of Health and Human Services (HHS) published the Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA (U. S. Department of Health Human Services, 2010). The Guidance provided a set of recommended practices to companies synthesizing double-stranded DNA to encourage such companies to screen both their customers and requested sequences. Several of the largest DNA synthesis companies came together to form the International Gene Synthesis Consortium (IGSC), a trade industry organization intended to promote the beneficial application of gene synthesis technology while safeguarding biosecurity.”

Key Target Audience
Pharmaceutical and Drug Manufacturers, Biotechnology Companies, Chemical and Biofuel Industries, Academic and Government Research Institutes, Venture Capitalists and Investment Banks, Potential Investors, Government Bodies, Business Research and Consulting Service Providers and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Gene Library Synthesis
  • Custom Gene Synthesis
By Application
  • Industrial
  • Academic
  • Therapeutics
  • Diagnostics
By Method
  • Solid Phase Synthesis
  • Chip Based DNA Synthesis
  • PCR Based Enzymes Synthesis

By End User
  • Contract Research Organizations
  • Biopharmaceutical Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Emphasis on Clinical Research
      • 3.2.2. Increasing Focus on the Life Science Research
    • 3.3. Market Challenges
      • 3.3.1. Lack of Advanced Healthcare Facilities in the Emerging Economies
    • 3.4. Market Trends
      • 3.4.1. Increasing Applications in the Recombinant DNA Technology
      • 3.4.2. Technological Advancement in the Gene Synthesis Techniques and Tools
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Gene Synthesis, by Type, Application, Method, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Gene Synthesis (Value)
      • 5.2.1. Global Gene Synthesis by: Type (Value)
        • 5.2.1.1. Gene Library Synthesis
        • 5.2.1.2. Custom Gene Synthesis
      • 5.2.2. Global Gene Synthesis by: Application (Value)
        • 5.2.2.1. Industrial
        • 5.2.2.2. Academic
        • 5.2.2.3. Therapeutics
        • 5.2.2.4. Diagnostics
      • 5.2.3. Global Gene Synthesis by: Method (Value)
        • 5.2.3.1. Solid Phase Synthesis
        • 5.2.3.2. Chip Based DNA Synthesis
        • 5.2.3.3. PCR Based Enzymes Synthesis
      • 5.2.4. Global Gene Synthesis by: End User (Value)
        • 5.2.4.1. Contract Research Organizations
        • 5.2.4.2. Biopharmaceutical Companies
      • 5.2.5. Global Gene Synthesis Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Gene Synthesis (Price)
      • 5.3.1. Global Gene Synthesis by: Type (Price)
  • 6. Gene Synthesis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Genewiz (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eurofins Scientific (Luxembourg)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ATD Bio Ltd. (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. OriGene Technologies, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bioneer Corporation (South Korea)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Integrated DNA Technologies, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GenScript Biotech Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eurogentec (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Gene Synthesis Sale, by Type, Application, Method, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Gene Synthesis (Value)
      • 7.2.1. Global Gene Synthesis by: Type (Value)
        • 7.2.1.1. Gene Library Synthesis
        • 7.2.1.2. Custom Gene Synthesis
      • 7.2.2. Global Gene Synthesis by: Application (Value)
        • 7.2.2.1. Industrial
        • 7.2.2.2. Academic
        • 7.2.2.3. Therapeutics
        • 7.2.2.4. Diagnostics
      • 7.2.3. Global Gene Synthesis by: Method (Value)
        • 7.2.3.1. Solid Phase Synthesis
        • 7.2.3.2. Chip Based DNA Synthesis
        • 7.2.3.3. PCR Based Enzymes Synthesis
      • 7.2.4. Global Gene Synthesis by: End User (Value)
        • 7.2.4.1. Contract Research Organizations
        • 7.2.4.2. Biopharmaceutical Companies
      • 7.2.5. Global Gene Synthesis Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Gene Synthesis (Price)
      • 7.3.1. Global Gene Synthesis by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Gene Synthesis: by Type(USD Million)
  • Table 2. Gene Synthesis Gene Library Synthesis , by Region USD Million (2018-2023)
  • Table 3. Gene Synthesis Custom Gene Synthesis , by Region USD Million (2018-2023)
  • Table 4. Gene Synthesis: by Application(USD Million)
  • Table 5. Gene Synthesis Industrial , by Region USD Million (2018-2023)
  • Table 6. Gene Synthesis Academic , by Region USD Million (2018-2023)
  • Table 7. Gene Synthesis Therapeutics , by Region USD Million (2018-2023)
  • Table 8. Gene Synthesis Diagnostics , by Region USD Million (2018-2023)
  • Table 9. Gene Synthesis: by Method(USD Million)
  • Table 10. Gene Synthesis Solid Phase Synthesis , by Region USD Million (2018-2023)
  • Table 11. Gene Synthesis Chip Based DNA Synthesis , by Region USD Million (2018-2023)
  • Table 12. Gene Synthesis PCR Based Enzymes Synthesis , by Region USD Million (2018-2023)
  • Table 13. Gene Synthesis: by End User(USD Million)
  • Table 14. Gene Synthesis Contract Research Organizations , by Region USD Million (2018-2023)
  • Table 15. Gene Synthesis Biopharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 16. South America Gene Synthesis, by Country USD Million (2018-2023)
  • Table 17. South America Gene Synthesis, by Type USD Million (2018-2023)
  • Table 18. South America Gene Synthesis, by Application USD Million (2018-2023)
  • Table 19. South America Gene Synthesis, by Method USD Million (2018-2023)
  • Table 20. South America Gene Synthesis, by End User USD Million (2018-2023)
  • Table 21. Brazil Gene Synthesis, by Type USD Million (2018-2023)
  • Table 22. Brazil Gene Synthesis, by Application USD Million (2018-2023)
  • Table 23. Brazil Gene Synthesis, by Method USD Million (2018-2023)
  • Table 24. Brazil Gene Synthesis, by End User USD Million (2018-2023)
  • Table 25. Argentina Gene Synthesis, by Type USD Million (2018-2023)
  • Table 26. Argentina Gene Synthesis, by Application USD Million (2018-2023)
  • Table 27. Argentina Gene Synthesis, by Method USD Million (2018-2023)
  • Table 28. Argentina Gene Synthesis, by End User USD Million (2018-2023)
  • Table 29. Rest of South America Gene Synthesis, by Type USD Million (2018-2023)
  • Table 30. Rest of South America Gene Synthesis, by Application USD Million (2018-2023)
  • Table 31. Rest of South America Gene Synthesis, by Method USD Million (2018-2023)
  • Table 32. Rest of South America Gene Synthesis, by End User USD Million (2018-2023)
  • Table 33. Asia Pacific Gene Synthesis, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Gene Synthesis, by Type USD Million (2018-2023)
  • Table 35. Asia Pacific Gene Synthesis, by Application USD Million (2018-2023)
  • Table 36. Asia Pacific Gene Synthesis, by Method USD Million (2018-2023)
  • Table 37. Asia Pacific Gene Synthesis, by End User USD Million (2018-2023)
  • Table 38. China Gene Synthesis, by Type USD Million (2018-2023)
  • Table 39. China Gene Synthesis, by Application USD Million (2018-2023)
  • Table 40. China Gene Synthesis, by Method USD Million (2018-2023)
  • Table 41. China Gene Synthesis, by End User USD Million (2018-2023)
  • Table 42. Japan Gene Synthesis, by Type USD Million (2018-2023)
  • Table 43. Japan Gene Synthesis, by Application USD Million (2018-2023)
  • Table 44. Japan Gene Synthesis, by Method USD Million (2018-2023)
  • Table 45. Japan Gene Synthesis, by End User USD Million (2018-2023)
  • Table 46. India Gene Synthesis, by Type USD Million (2018-2023)
  • Table 47. India Gene Synthesis, by Application USD Million (2018-2023)
  • Table 48. India Gene Synthesis, by Method USD Million (2018-2023)
  • Table 49. India Gene Synthesis, by End User USD Million (2018-2023)
  • Table 50. South Korea Gene Synthesis, by Type USD Million (2018-2023)
  • Table 51. South Korea Gene Synthesis, by Application USD Million (2018-2023)
  • Table 52. South Korea Gene Synthesis, by Method USD Million (2018-2023)
  • Table 53. South Korea Gene Synthesis, by End User USD Million (2018-2023)
  • Table 54. Taiwan Gene Synthesis, by Type USD Million (2018-2023)
  • Table 55. Taiwan Gene Synthesis, by Application USD Million (2018-2023)
  • Table 56. Taiwan Gene Synthesis, by Method USD Million (2018-2023)
  • Table 57. Taiwan Gene Synthesis, by End User USD Million (2018-2023)
  • Table 58. Australia Gene Synthesis, by Type USD Million (2018-2023)
  • Table 59. Australia Gene Synthesis, by Application USD Million (2018-2023)
  • Table 60. Australia Gene Synthesis, by Method USD Million (2018-2023)
  • Table 61. Australia Gene Synthesis, by End User USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Gene Synthesis, by Type USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Gene Synthesis, by Application USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Gene Synthesis, by Method USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Gene Synthesis, by End User USD Million (2018-2023)
  • Table 66. Europe Gene Synthesis, by Country USD Million (2018-2023)
  • Table 67. Europe Gene Synthesis, by Type USD Million (2018-2023)
  • Table 68. Europe Gene Synthesis, by Application USD Million (2018-2023)
  • Table 69. Europe Gene Synthesis, by Method USD Million (2018-2023)
  • Table 70. Europe Gene Synthesis, by End User USD Million (2018-2023)
  • Table 71. Germany Gene Synthesis, by Type USD Million (2018-2023)
  • Table 72. Germany Gene Synthesis, by Application USD Million (2018-2023)
  • Table 73. Germany Gene Synthesis, by Method USD Million (2018-2023)
  • Table 74. Germany Gene Synthesis, by End User USD Million (2018-2023)
  • Table 75. France Gene Synthesis, by Type USD Million (2018-2023)
  • Table 76. France Gene Synthesis, by Application USD Million (2018-2023)
  • Table 77. France Gene Synthesis, by Method USD Million (2018-2023)
  • Table 78. France Gene Synthesis, by End User USD Million (2018-2023)
  • Table 79. Italy Gene Synthesis, by Type USD Million (2018-2023)
  • Table 80. Italy Gene Synthesis, by Application USD Million (2018-2023)
  • Table 81. Italy Gene Synthesis, by Method USD Million (2018-2023)
  • Table 82. Italy Gene Synthesis, by End User USD Million (2018-2023)
  • Table 83. United Kingdom Gene Synthesis, by Type USD Million (2018-2023)
  • Table 84. United Kingdom Gene Synthesis, by Application USD Million (2018-2023)
  • Table 85. United Kingdom Gene Synthesis, by Method USD Million (2018-2023)
  • Table 86. United Kingdom Gene Synthesis, by End User USD Million (2018-2023)
  • Table 87. Netherlands Gene Synthesis, by Type USD Million (2018-2023)
  • Table 88. Netherlands Gene Synthesis, by Application USD Million (2018-2023)
  • Table 89. Netherlands Gene Synthesis, by Method USD Million (2018-2023)
  • Table 90. Netherlands Gene Synthesis, by End User USD Million (2018-2023)
  • Table 91. Rest of Europe Gene Synthesis, by Type USD Million (2018-2023)
  • Table 92. Rest of Europe Gene Synthesis, by Application USD Million (2018-2023)
  • Table 93. Rest of Europe Gene Synthesis, by Method USD Million (2018-2023)
  • Table 94. Rest of Europe Gene Synthesis, by End User USD Million (2018-2023)
  • Table 95. MEA Gene Synthesis, by Country USD Million (2018-2023)
  • Table 96. MEA Gene Synthesis, by Type USD Million (2018-2023)
  • Table 97. MEA Gene Synthesis, by Application USD Million (2018-2023)
  • Table 98. MEA Gene Synthesis, by Method USD Million (2018-2023)
  • Table 99. MEA Gene Synthesis, by End User USD Million (2018-2023)
  • Table 100. Middle East Gene Synthesis, by Type USD Million (2018-2023)
  • Table 101. Middle East Gene Synthesis, by Application USD Million (2018-2023)
  • Table 102. Middle East Gene Synthesis, by Method USD Million (2018-2023)
  • Table 103. Middle East Gene Synthesis, by End User USD Million (2018-2023)
  • Table 104. Africa Gene Synthesis, by Type USD Million (2018-2023)
  • Table 105. Africa Gene Synthesis, by Application USD Million (2018-2023)
  • Table 106. Africa Gene Synthesis, by Method USD Million (2018-2023)
  • Table 107. Africa Gene Synthesis, by End User USD Million (2018-2023)
  • Table 108. North America Gene Synthesis, by Country USD Million (2018-2023)
  • Table 109. North America Gene Synthesis, by Type USD Million (2018-2023)
  • Table 110. North America Gene Synthesis, by Application USD Million (2018-2023)
  • Table 111. North America Gene Synthesis, by Method USD Million (2018-2023)
  • Table 112. North America Gene Synthesis, by End User USD Million (2018-2023)
  • Table 113. United States Gene Synthesis, by Type USD Million (2018-2023)
  • Table 114. United States Gene Synthesis, by Application USD Million (2018-2023)
  • Table 115. United States Gene Synthesis, by Method USD Million (2018-2023)
  • Table 116. United States Gene Synthesis, by End User USD Million (2018-2023)
  • Table 117. Canada Gene Synthesis, by Type USD Million (2018-2023)
  • Table 118. Canada Gene Synthesis, by Application USD Million (2018-2023)
  • Table 119. Canada Gene Synthesis, by Method USD Million (2018-2023)
  • Table 120. Canada Gene Synthesis, by End User USD Million (2018-2023)
  • Table 121. Mexico Gene Synthesis, by Type USD Million (2018-2023)
  • Table 122. Mexico Gene Synthesis, by Application USD Million (2018-2023)
  • Table 123. Mexico Gene Synthesis, by Method USD Million (2018-2023)
  • Table 124. Mexico Gene Synthesis, by End User USD Million (2018-2023)
  • Table 125. Gene Synthesis: by Type(USD/Units)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Gene Synthesis: by Type(USD Million)
  • Table 136. Gene Synthesis Gene Library Synthesis , by Region USD Million (2025-2030)
  • Table 137. Gene Synthesis Custom Gene Synthesis , by Region USD Million (2025-2030)
  • Table 138. Gene Synthesis: by Application(USD Million)
  • Table 139. Gene Synthesis Industrial , by Region USD Million (2025-2030)
  • Table 140. Gene Synthesis Academic , by Region USD Million (2025-2030)
  • Table 141. Gene Synthesis Therapeutics , by Region USD Million (2025-2030)
  • Table 142. Gene Synthesis Diagnostics , by Region USD Million (2025-2030)
  • Table 143. Gene Synthesis: by Method(USD Million)
  • Table 144. Gene Synthesis Solid Phase Synthesis , by Region USD Million (2025-2030)
  • Table 145. Gene Synthesis Chip Based DNA Synthesis , by Region USD Million (2025-2030)
  • Table 146. Gene Synthesis PCR Based Enzymes Synthesis , by Region USD Million (2025-2030)
  • Table 147. Gene Synthesis: by End User(USD Million)
  • Table 148. Gene Synthesis Contract Research Organizations , by Region USD Million (2025-2030)
  • Table 149. Gene Synthesis Biopharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 150. South America Gene Synthesis, by Country USD Million (2025-2030)
  • Table 151. South America Gene Synthesis, by Type USD Million (2025-2030)
  • Table 152. South America Gene Synthesis, by Application USD Million (2025-2030)
  • Table 153. South America Gene Synthesis, by Method USD Million (2025-2030)
  • Table 154. South America Gene Synthesis, by End User USD Million (2025-2030)
  • Table 155. Brazil Gene Synthesis, by Type USD Million (2025-2030)
  • Table 156. Brazil Gene Synthesis, by Application USD Million (2025-2030)
  • Table 157. Brazil Gene Synthesis, by Method USD Million (2025-2030)
  • Table 158. Brazil Gene Synthesis, by End User USD Million (2025-2030)
  • Table 159. Argentina Gene Synthesis, by Type USD Million (2025-2030)
  • Table 160. Argentina Gene Synthesis, by Application USD Million (2025-2030)
  • Table 161. Argentina Gene Synthesis, by Method USD Million (2025-2030)
  • Table 162. Argentina Gene Synthesis, by End User USD Million (2025-2030)
  • Table 163. Rest of South America Gene Synthesis, by Type USD Million (2025-2030)
  • Table 164. Rest of South America Gene Synthesis, by Application USD Million (2025-2030)
  • Table 165. Rest of South America Gene Synthesis, by Method USD Million (2025-2030)
  • Table 166. Rest of South America Gene Synthesis, by End User USD Million (2025-2030)
  • Table 167. Asia Pacific Gene Synthesis, by Country USD Million (2025-2030)
  • Table 168. Asia Pacific Gene Synthesis, by Type USD Million (2025-2030)
  • Table 169. Asia Pacific Gene Synthesis, by Application USD Million (2025-2030)
  • Table 170. Asia Pacific Gene Synthesis, by Method USD Million (2025-2030)
  • Table 171. Asia Pacific Gene Synthesis, by End User USD Million (2025-2030)
  • Table 172. China Gene Synthesis, by Type USD Million (2025-2030)
  • Table 173. China Gene Synthesis, by Application USD Million (2025-2030)
  • Table 174. China Gene Synthesis, by Method USD Million (2025-2030)
  • Table 175. China Gene Synthesis, by End User USD Million (2025-2030)
  • Table 176. Japan Gene Synthesis, by Type USD Million (2025-2030)
  • Table 177. Japan Gene Synthesis, by Application USD Million (2025-2030)
  • Table 178. Japan Gene Synthesis, by Method USD Million (2025-2030)
  • Table 179. Japan Gene Synthesis, by End User USD Million (2025-2030)
  • Table 180. India Gene Synthesis, by Type USD Million (2025-2030)
  • Table 181. India Gene Synthesis, by Application USD Million (2025-2030)
  • Table 182. India Gene Synthesis, by Method USD Million (2025-2030)
  • Table 183. India Gene Synthesis, by End User USD Million (2025-2030)
  • Table 184. South Korea Gene Synthesis, by Type USD Million (2025-2030)
  • Table 185. South Korea Gene Synthesis, by Application USD Million (2025-2030)
  • Table 186. South Korea Gene Synthesis, by Method USD Million (2025-2030)
  • Table 187. South Korea Gene Synthesis, by End User USD Million (2025-2030)
  • Table 188. Taiwan Gene Synthesis, by Type USD Million (2025-2030)
  • Table 189. Taiwan Gene Synthesis, by Application USD Million (2025-2030)
  • Table 190. Taiwan Gene Synthesis, by Method USD Million (2025-2030)
  • Table 191. Taiwan Gene Synthesis, by End User USD Million (2025-2030)
  • Table 192. Australia Gene Synthesis, by Type USD Million (2025-2030)
  • Table 193. Australia Gene Synthesis, by Application USD Million (2025-2030)
  • Table 194. Australia Gene Synthesis, by Method USD Million (2025-2030)
  • Table 195. Australia Gene Synthesis, by End User USD Million (2025-2030)
  • Table 196. Rest of Asia-Pacific Gene Synthesis, by Type USD Million (2025-2030)
  • Table 197. Rest of Asia-Pacific Gene Synthesis, by Application USD Million (2025-2030)
  • Table 198. Rest of Asia-Pacific Gene Synthesis, by Method USD Million (2025-2030)
  • Table 199. Rest of Asia-Pacific Gene Synthesis, by End User USD Million (2025-2030)
  • Table 200. Europe Gene Synthesis, by Country USD Million (2025-2030)
  • Table 201. Europe Gene Synthesis, by Type USD Million (2025-2030)
  • Table 202. Europe Gene Synthesis, by Application USD Million (2025-2030)
  • Table 203. Europe Gene Synthesis, by Method USD Million (2025-2030)
  • Table 204. Europe Gene Synthesis, by End User USD Million (2025-2030)
  • Table 205. Germany Gene Synthesis, by Type USD Million (2025-2030)
  • Table 206. Germany Gene Synthesis, by Application USD Million (2025-2030)
  • Table 207. Germany Gene Synthesis, by Method USD Million (2025-2030)
  • Table 208. Germany Gene Synthesis, by End User USD Million (2025-2030)
  • Table 209. France Gene Synthesis, by Type USD Million (2025-2030)
  • Table 210. France Gene Synthesis, by Application USD Million (2025-2030)
  • Table 211. France Gene Synthesis, by Method USD Million (2025-2030)
  • Table 212. France Gene Synthesis, by End User USD Million (2025-2030)
  • Table 213. Italy Gene Synthesis, by Type USD Million (2025-2030)
  • Table 214. Italy Gene Synthesis, by Application USD Million (2025-2030)
  • Table 215. Italy Gene Synthesis, by Method USD Million (2025-2030)
  • Table 216. Italy Gene Synthesis, by End User USD Million (2025-2030)
  • Table 217. United Kingdom Gene Synthesis, by Type USD Million (2025-2030)
  • Table 218. United Kingdom Gene Synthesis, by Application USD Million (2025-2030)
  • Table 219. United Kingdom Gene Synthesis, by Method USD Million (2025-2030)
  • Table 220. United Kingdom Gene Synthesis, by End User USD Million (2025-2030)
  • Table 221. Netherlands Gene Synthesis, by Type USD Million (2025-2030)
  • Table 222. Netherlands Gene Synthesis, by Application USD Million (2025-2030)
  • Table 223. Netherlands Gene Synthesis, by Method USD Million (2025-2030)
  • Table 224. Netherlands Gene Synthesis, by End User USD Million (2025-2030)
  • Table 225. Rest of Europe Gene Synthesis, by Type USD Million (2025-2030)
  • Table 226. Rest of Europe Gene Synthesis, by Application USD Million (2025-2030)
  • Table 227. Rest of Europe Gene Synthesis, by Method USD Million (2025-2030)
  • Table 228. Rest of Europe Gene Synthesis, by End User USD Million (2025-2030)
  • Table 229. MEA Gene Synthesis, by Country USD Million (2025-2030)
  • Table 230. MEA Gene Synthesis, by Type USD Million (2025-2030)
  • Table 231. MEA Gene Synthesis, by Application USD Million (2025-2030)
  • Table 232. MEA Gene Synthesis, by Method USD Million (2025-2030)
  • Table 233. MEA Gene Synthesis, by End User USD Million (2025-2030)
  • Table 234. Middle East Gene Synthesis, by Type USD Million (2025-2030)
  • Table 235. Middle East Gene Synthesis, by Application USD Million (2025-2030)
  • Table 236. Middle East Gene Synthesis, by Method USD Million (2025-2030)
  • Table 237. Middle East Gene Synthesis, by End User USD Million (2025-2030)
  • Table 238. Africa Gene Synthesis, by Type USD Million (2025-2030)
  • Table 239. Africa Gene Synthesis, by Application USD Million (2025-2030)
  • Table 240. Africa Gene Synthesis, by Method USD Million (2025-2030)
  • Table 241. Africa Gene Synthesis, by End User USD Million (2025-2030)
  • Table 242. North America Gene Synthesis, by Country USD Million (2025-2030)
  • Table 243. North America Gene Synthesis, by Type USD Million (2025-2030)
  • Table 244. North America Gene Synthesis, by Application USD Million (2025-2030)
  • Table 245. North America Gene Synthesis, by Method USD Million (2025-2030)
  • Table 246. North America Gene Synthesis, by End User USD Million (2025-2030)
  • Table 247. United States Gene Synthesis, by Type USD Million (2025-2030)
  • Table 248. United States Gene Synthesis, by Application USD Million (2025-2030)
  • Table 249. United States Gene Synthesis, by Method USD Million (2025-2030)
  • Table 250. United States Gene Synthesis, by End User USD Million (2025-2030)
  • Table 251. Canada Gene Synthesis, by Type USD Million (2025-2030)
  • Table 252. Canada Gene Synthesis, by Application USD Million (2025-2030)
  • Table 253. Canada Gene Synthesis, by Method USD Million (2025-2030)
  • Table 254. Canada Gene Synthesis, by End User USD Million (2025-2030)
  • Table 255. Mexico Gene Synthesis, by Type USD Million (2025-2030)
  • Table 256. Mexico Gene Synthesis, by Application USD Million (2025-2030)
  • Table 257. Mexico Gene Synthesis, by Method USD Million (2025-2030)
  • Table 258. Mexico Gene Synthesis, by End User USD Million (2025-2030)
  • Table 259. Gene Synthesis: by Type(USD/Units)
  • Table 260. Research Programs/Design for This Report
  • Table 261. Key Data Information from Secondary Sources
  • Table 262. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Gene Synthesis: by Type USD Million (2018-2023)
  • Figure 5. Global Gene Synthesis: by Application USD Million (2018-2023)
  • Figure 6. Global Gene Synthesis: by Method USD Million (2018-2023)
  • Figure 7. Global Gene Synthesis: by End User USD Million (2018-2023)
  • Figure 8. South America Gene Synthesis Share (%), by Country
  • Figure 9. Asia Pacific Gene Synthesis Share (%), by Country
  • Figure 10. Europe Gene Synthesis Share (%), by Country
  • Figure 11. MEA Gene Synthesis Share (%), by Country
  • Figure 12. North America Gene Synthesis Share (%), by Country
  • Figure 13. Global Gene Synthesis: by Type USD/Units (2018-2023)
  • Figure 14. Global Gene Synthesis share by Players 2023 (%)
  • Figure 15. Global Gene Synthesis share by Players (Top 3) 2023(%)
  • Figure 16. Global Gene Synthesis share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Genewiz (United States) Revenue, Net Income and Gross profit
  • Figure 21. Genewiz (United States) Revenue: by Geography 2023
  • Figure 22. Eurofins Scientific (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 23. Eurofins Scientific (Luxembourg) Revenue: by Geography 2023
  • Figure 24. ATD Bio Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. ATD Bio Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 26. OriGene Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. OriGene Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Bioneer Corporation (South Korea) Revenue, Net Income and Gross profit
  • Figure 29. Bioneer Corporation (South Korea) Revenue: by Geography 2023
  • Figure 30. Integrated DNA Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Integrated DNA Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 32. GenScript Biotech Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. GenScript Biotech Corporation (United States) Revenue: by Geography 2023
  • Figure 34. Eurogentec (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Eurogentec (Japan) Revenue: by Geography 2023
  • Figure 36. Global Gene Synthesis: by Type USD Million (2025-2030)
  • Figure 37. Global Gene Synthesis: by Application USD Million (2025-2030)
  • Figure 38. Global Gene Synthesis: by Method USD Million (2025-2030)
  • Figure 39. Global Gene Synthesis: by End User USD Million (2025-2030)
  • Figure 40. South America Gene Synthesis Share (%), by Country
  • Figure 41. Asia Pacific Gene Synthesis Share (%), by Country
  • Figure 42. Europe Gene Synthesis Share (%), by Country
  • Figure 43. MEA Gene Synthesis Share (%), by Country
  • Figure 44. North America Gene Synthesis Share (%), by Country
  • Figure 45. Global Gene Synthesis: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc. (United States)
  • Genewiz (United States)
  • Eurofins Scientific (Luxembourg)
  • ATD Bio Ltd. (United Kingdom)
  • OriGene Technologies, Inc. (United States)
  • Bioneer Corporation (South Korea)
  • Integrated DNA Technologies, Inc. (United States)
  • GenScript Biotech Corporation (United States)
  • Eurogentec (Japan)
Additional players considered in the study are as follows:
ATDBio Ltd (United Kingdom) , Vigene Biosciences (United States) , Synbio Technologies (United States) ,
Select User Access Type

Key Highlights of Report


Mar 2024 201 Pages 64 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Gene Synthesis research Quantitative research analysis
Global Gene Synthesis research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific, Inc. (United States), Genewiz (United States), Eurofins Scientific (Luxembourg), ATD Bio Ltd. (United Kingdom), OriGene Technologies, Inc. (United States), Bioneer Corporation (South Korea), Integrated DNA Technologies, Inc. (United States), GenScript Biotech Corporation (United States) and Eurogentec (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Applications in the Recombinant DNA Technology " is seen as one of major influencing trends for Gene Synthesis Market during projected period 2023-2030.
The Gene Synthesis market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Gene Synthesis research Report?

Have a Query? Click Here

Other Related Reports

Industrial Automation in Life Sciences Comprehensive Study by Type (DCS (Distributed Control System), PLC ( Programmable Logic Controller), SCADA (Supervisory Control & Data Acquisition), MES (Milita...
$ 3650
Microscope Glass Covers Comprehensive Study by Type (Circle Microscope Glass Covers, Square Microscope Glass Covers, Rectangle Microscope Glass Covers), Application (Medical, Scientific Research, Aca...
$ 3750
Hematopoietic Stem Cell Transplantation Comprehensive Study by Type (Allogeneic, Autologous), Application (Peripheral Blood Stem Cells Transplant (PBSCT), Bone Marrow Transplant (BMT), Cord Blood Tra...
$ 3750
Stem Cells Comprehensive Study by Type (Adult Stem Cells (Neuronal, Hematopoietic, Mesenchymal, Umbilical Cord, Others), Human Embryonic Stem Cells (hESC), Induced Pluripotent Stem Cells, Very Small ...
$ 3750
Viral Disease Diagnosis Comprehensive Study by Diagnostic Test (Serodiagnostic Tests, Specimen Examination, Viral Isolation), Virus (Dengue virus, Hepatitis virus, HIV-1, Human Metapneumovirus, Meas...
$ 3650
Molecular Weight Marker Comprehensive Study by Type (DNA Markers (Below 50 bp, 50 bp to 100 bp, 100 bp to 1 kb, 1 kb to 5 kb, Above 5 kb), Protein Markers (Below 10 kDa, 10 k Da to 100 kDa, 100 k Da ...
$ 3750